Dr. Daniel Gregory Luba, MD

Dr. Luba practices at Monterey Bay Endoscopy Center in Monterey, California.

Dr. Luba's NPI, 1790786002, was assigned on August 9, 2005. Dr. Luba graduated from Boston University School Of Medicine in 1985. Dr. Luba holds California license G646260.

Dr. Luba's primary practice is Monterey Bay Endoscopy Center, at 23 Upper Ragsdale Drive, Suite 100, Monterey, CA 93940. The practice phone is (831) 375-3577.

Dr. Luba's primary practice is Monterey Bay Endoscopy Center in Monterey, California. Dr. Luba is also affiliated with Community Hospital of the Monterey Peninsula. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Luba to 3 more hospitals, 3 medical groups, 2 group practices and clinics and 1 rural health clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Luba practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Luba's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Luba is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Luba is licensed in California.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Luba treats.

CMS data shows 4,227 Medicare services from Dr. Luba across 24 procedure codes in 2024, for 1,762 Medicare patients. Medicare paid $334,220 for them.

CMS counts 1,762 Medicare patients who saw Dr. Luba in 2024. The largest group is 65 to 74, with 1,051 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 20% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Luba's median patient age at 61, with 55% women.

In 2024, Dr. Luba wrote 912 Medicare Part D claims for 390 patients. 90% of them were for generic drugs. CMS names the drug for 749 of them, across 12 drugs with 11 or more claims each, at $28,912 in total drug cost. In 2023, CMS named 787 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Luba for performance year 2024, reported as part of a group. Dr. Luba accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Luba as offering telehealth. CMS counts 402 procedures of colonoscopy by Dr. Luba, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Luba, published from 2011 to 2019. 2017 was the busiest year, with 2. Dr. Luba's most frequent co-authors are Fay Kastrinos, MD, Randall W. Burt, MD and Harry B. Greenberg, MD.

CMS Open Payments shows 313 general payments to Dr. Luba from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $1,160.

Dmand AI lists 1 award for Dr. Luba, most recently CMS Stage 1 EHR in 2013.

Dr. Luba graduated from Boston University School Of Medicine in 1985.

Dr. Luba is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.